Copyright Reports & Markets. All rights reserved.

Global Nanoparticle-Mediated Delivery Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Nanoparticle-Mediated Delivery
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Nanoparticle-Mediated Delivery by Type
    • 1.3.1 Overview: Global Nanoparticle-Mediated Delivery Market Size by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Global Nanoparticle-Mediated Delivery Consumption Value Market Share by Type in 2022
    • 1.3.3 Biological Origin
    • 1.3.4 Non-Biological Origin
  • 1.4 Global Nanoparticle-Mediated Delivery Market by Application
    • 1.4.1 Overview: Global Nanoparticle-Mediated Delivery Market Size by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Drug Delivery
    • 1.4.3 Gene Delivery
  • 1.5 Global Nanoparticle-Mediated Delivery Market Size & Forecast
  • 1.6 Global Nanoparticle-Mediated Delivery Market Size and Forecast by Region
    • 1.6.1 Global Nanoparticle-Mediated Delivery Market Size by Region: 2018 VS 2022 VS 2029
    • 1.6.2 Global Nanoparticle-Mediated Delivery Market Size by Region, (2018-2029)
    • 1.6.3 North America Nanoparticle-Mediated Delivery Market Size and Prospect (2018-2029)
    • 1.6.4 Europe Nanoparticle-Mediated Delivery Market Size and Prospect (2018-2029)
    • 1.6.5 Asia-Pacific Nanoparticle-Mediated Delivery Market Size and Prospect (2018-2029)
    • 1.6.6 South America Nanoparticle-Mediated Delivery Market Size and Prospect (2018-2029)
    • 1.6.7 Middle East and Africa Nanoparticle-Mediated Delivery Market Size and Prospect (2018-2029)

2 Company Profiles

  • 2.1 AbbVie
    • 2.1.1 AbbVie Details
    • 2.1.2 AbbVie Major Business
    • 2.1.3 AbbVie Nanoparticle-Mediated Delivery Product and Solutions
    • 2.1.4 AbbVie Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 AbbVie Recent Developments and Future Plans
  • 2.2 BlueWillow Biologics
    • 2.2.1 BlueWillow Biologics Details
    • 2.2.2 BlueWillow Biologics Major Business
    • 2.2.3 BlueWillow Biologics Nanoparticle-Mediated Delivery Product and Solutions
    • 2.2.4 BlueWillow Biologics Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 BlueWillow Biologics Recent Developments and Future Plans
  • 2.3 NovaSOL
    • 2.3.1 NovaSOL Details
    • 2.3.2 NovaSOL Major Business
    • 2.3.3 NovaSOL Nanoparticle-Mediated Delivery Product and Solutions
    • 2.3.4 NovaSOL Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 NovaSOL Recent Developments and Future Plans
  • 2.4 Camurus
    • 2.4.1 Camurus Details
    • 2.4.2 Camurus Major Business
    • 2.4.3 Camurus Nanoparticle-Mediated Delivery Product and Solutions
    • 2.4.4 Camurus Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Camurus Recent Developments and Future Plans
  • 2.5 Ceramisphere
    • 2.5.1 Ceramisphere Details
    • 2.5.2 Ceramisphere Major Business
    • 2.5.3 Ceramisphere Nanoparticle-Mediated Delivery Product and Solutions
    • 2.5.4 Ceramisphere Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Ceramisphere Recent Developments and Future Plans
  • 2.6 Celgene, CytImmune
    • 2.6.1 Celgene, CytImmune Details
    • 2.6.2 Celgene, CytImmune Major Business
    • 2.6.3 Celgene, CytImmune Nanoparticle-Mediated Delivery Product and Solutions
    • 2.6.4 Celgene, CytImmune Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Celgene, CytImmune Recent Developments and Future Plans
  • 2.7 Cristal Therapeutics
    • 2.7.1 Cristal Therapeutics Details
    • 2.7.2 Cristal Therapeutics Major Business
    • 2.7.3 Cristal Therapeutics Nanoparticle-Mediated Delivery Product and Solutions
    • 2.7.4 Cristal Therapeutics Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Cristal Therapeutics Recent Developments and Future Plans
  • 2.8 EnColl
    • 2.8.1 EnColl Details
    • 2.8.2 EnColl Major Business
    • 2.8.3 EnColl Nanoparticle-Mediated Delivery Product and Solutions
    • 2.8.4 EnColl Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 EnColl Recent Developments and Future Plans
  • 2.9 Lena Nanoceutics Ltd.
    • 2.9.1 Lena Nanoceutics Ltd. Details
    • 2.9.2 Lena Nanoceutics Ltd. Major Business
    • 2.9.3 Lena Nanoceutics Ltd. Nanoparticle-Mediated Delivery Product and Solutions
    • 2.9.4 Lena Nanoceutics Ltd. Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Lena Nanoceutics Ltd. Recent Developments and Future Plans
  • 2.10 EyePoint Pharmaceuticals
    • 2.10.1 EyePoint Pharmaceuticals Details
    • 2.10.2 EyePoint Pharmaceuticals Major Business
    • 2.10.3 EyePoint Pharmaceuticals Nanoparticle-Mediated Delivery Product and Solutions
    • 2.10.4 EyePoint Pharmaceuticals Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 EyePoint Pharmaceuticals Recent Developments and Future Plans
  • 2.11 Nanobiotix
    • 2.11.1 Nanobiotix Details
    • 2.11.2 Nanobiotix Major Business
    • 2.11.3 Nanobiotix Nanoparticle-Mediated Delivery Product and Solutions
    • 2.11.4 Nanobiotix Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Nanobiotix Recent Developments and Future Plans
  • 2.12 NanoCarrier
    • 2.12.1 NanoCarrier Details
    • 2.12.2 NanoCarrier Major Business
    • 2.12.3 NanoCarrier Nanoparticle-Mediated Delivery Product and Solutions
    • 2.12.4 NanoCarrier Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 NanoCarrier Recent Developments and Future Plans
  • 2.13 Nanospectra
    • 2.13.1 Nanospectra Details
    • 2.13.2 Nanospectra Major Business
    • 2.13.3 Nanospectra Nanoparticle-Mediated Delivery Product and Solutions
    • 2.13.4 Nanospectra Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Nanospectra Recent Developments and Future Plans
  • 2.14 NanOlogy
    • 2.14.1 NanOlogy Details
    • 2.14.2 NanOlogy Major Business
    • 2.14.3 NanOlogy Nanoparticle-Mediated Delivery Product and Solutions
    • 2.14.4 NanOlogy Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 NanOlogy Recent Developments and Future Plans
  • 2.15 Selecta Biosciences
    • 2.15.1 Selecta Biosciences Details
    • 2.15.2 Selecta Biosciences Major Business
    • 2.15.3 Selecta Biosciences Nanoparticle-Mediated Delivery Product and Solutions
    • 2.15.4 Selecta Biosciences Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Selecta Biosciences Recent Developments and Future Plans
  • 2.16 Parvus Therapeutics
    • 2.16.1 Parvus Therapeutics Details
    • 2.16.2 Parvus Therapeutics Major Business
    • 2.16.3 Parvus Therapeutics Nanoparticle-Mediated Delivery Product and Solutions
    • 2.16.4 Parvus Therapeutics Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Parvus Therapeutics Recent Developments and Future Plans
  • 2.17 Starpharma
    • 2.17.1 Starpharma Details
    • 2.17.2 Starpharma Major Business
    • 2.17.3 Starpharma Nanoparticle-Mediated Delivery Product and Solutions
    • 2.17.4 Starpharma Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
    • 2.17.5 Starpharma Recent Developments and Future Plans
  • 2.18 Tarveda Therapeutics
    • 2.18.1 Tarveda Therapeutics Details
    • 2.18.2 Tarveda Therapeutics Major Business
    • 2.18.3 Tarveda Therapeutics Nanoparticle-Mediated Delivery Product and Solutions
    • 2.18.4 Tarveda Therapeutics Nanoparticle-Mediated Delivery Revenue, Gross Margin and Market Share (2018-2023)
    • 2.18.5 Tarveda Therapeutics Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Nanoparticle-Mediated Delivery Revenue and Share by Players (2018-2023)
  • 3.2 Market Share Analysis (2022)
    • 3.2.1 Market Share of Nanoparticle-Mediated Delivery by Company Revenue
    • 3.2.2 Top 3 Nanoparticle-Mediated Delivery Players Market Share in 2022
    • 3.2.3 Top 6 Nanoparticle-Mediated Delivery Players Market Share in 2022
  • 3.3 Nanoparticle-Mediated Delivery Market: Overall Company Footprint Analysis
    • 3.3.1 Nanoparticle-Mediated Delivery Market: Region Footprint
    • 3.3.2 Nanoparticle-Mediated Delivery Market: Company Product Type Footprint
    • 3.3.3 Nanoparticle-Mediated Delivery Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Nanoparticle-Mediated Delivery Consumption Value and Market Share by Type (2018-2023)
  • 4.2 Global Nanoparticle-Mediated Delivery Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

  • 5.1 Global Nanoparticle-Mediated Delivery Consumption Value Market Share by Application (2018-2023)
  • 5.2 Global Nanoparticle-Mediated Delivery Market Forecast by Application (2024-2029)

6 North America

  • 6.1 North America Nanoparticle-Mediated Delivery Consumption Value by Type (2018-2029)
  • 6.2 North America Nanoparticle-Mediated Delivery Consumption Value by Application (2018-2029)
  • 6.3 North America Nanoparticle-Mediated Delivery Market Size by Country
    • 6.3.1 North America Nanoparticle-Mediated Delivery Consumption Value by Country (2018-2029)
    • 6.3.2 United States Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
    • 6.3.3 Canada Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
    • 6.3.4 Mexico Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)

7 Europe

  • 7.1 Europe Nanoparticle-Mediated Delivery Consumption Value by Type (2018-2029)
  • 7.2 Europe Nanoparticle-Mediated Delivery Consumption Value by Application (2018-2029)
  • 7.3 Europe Nanoparticle-Mediated Delivery Market Size by Country
    • 7.3.1 Europe Nanoparticle-Mediated Delivery Consumption Value by Country (2018-2029)
    • 7.3.2 Germany Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
    • 7.3.3 France Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
    • 7.3.4 United Kingdom Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
    • 7.3.5 Russia Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
    • 7.3.6 Italy Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)

8 Asia-Pacific

  • 8.1 Asia-Pacific Nanoparticle-Mediated Delivery Consumption Value by Type (2018-2029)
  • 8.2 Asia-Pacific Nanoparticle-Mediated Delivery Consumption Value by Application (2018-2029)
  • 8.3 Asia-Pacific Nanoparticle-Mediated Delivery Market Size by Region
    • 8.3.1 Asia-Pacific Nanoparticle-Mediated Delivery Consumption Value by Region (2018-2029)
    • 8.3.2 China Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
    • 8.3.3 Japan Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
    • 8.3.4 South Korea Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
    • 8.3.5 India Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
    • 8.3.6 Southeast Asia Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
    • 8.3.7 Australia Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)

9 South America

  • 9.1 South America Nanoparticle-Mediated Delivery Consumption Value by Type (2018-2029)
  • 9.2 South America Nanoparticle-Mediated Delivery Consumption Value by Application (2018-2029)
  • 9.3 South America Nanoparticle-Mediated Delivery Market Size by Country
    • 9.3.1 South America Nanoparticle-Mediated Delivery Consumption Value by Country (2018-2029)
    • 9.3.2 Brazil Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
    • 9.3.3 Argentina Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)

10 Middle East & Africa

  • 10.1 Middle East & Africa Nanoparticle-Mediated Delivery Consumption Value by Type (2018-2029)
  • 10.2 Middle East & Africa Nanoparticle-Mediated Delivery Consumption Value by Application (2018-2029)
  • 10.3 Middle East & Africa Nanoparticle-Mediated Delivery Market Size by Country
    • 10.3.1 Middle East & Africa Nanoparticle-Mediated Delivery Consumption Value by Country (2018-2029)
    • 10.3.2 Turkey Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
    • 10.3.3 Saudi Arabia Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)
    • 10.3.4 UAE Nanoparticle-Mediated Delivery Market Size and Forecast (2018-2029)

11 Market Dynamics

  • 11.1 Nanoparticle-Mediated Delivery Market Drivers
  • 11.2 Nanoparticle-Mediated Delivery Market Restraints
  • 11.3 Nanoparticle-Mediated Delivery Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry
  • 11.5 Influence of COVID-19 and Russia-Ukraine War
    • 11.5.1 Influence of COVID-19
    • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

  • 12.1 Nanoparticle-Mediated Delivery Industry Chain
  • 12.2 Nanoparticle-Mediated Delivery Upstream Analysis
  • 12.3 Nanoparticle-Mediated Delivery Midstream Analysis
  • 12.4 Nanoparticle-Mediated Delivery Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Nanoparticle drug delivery systems are engineered technologies that use nanoparticles for the targeted delivery and controlled release of therapeutic agents. The modern form of a drug delivery system should minimize side-effects and reduce both dosage and dosage frequency. Recently, nanoparticles have aroused attention due to their potential application for effective drug delivery.
    In this report, we only study liposomal/lipid nanoparticle drug delivery system.

    LNPs became more widely known in late 2020, as some COVID-19 vaccines that use RNA vaccine technology coat the fragile mRNA strands with PEGylated lipid nanoparticles as their delivery vehicle (including both the Moderna and the Pfizer–BioNTech COVID-19 vaccines).
    In this report, the COVID-19 vaccines with lipid nanoparticles technologies are not covered. The COVID-19 vaccines launch on the end of 2020. We expect revenue for COVID-19 vaccines with lipid nanoparticles technologies in 2021 to be approximately 37 billion USD.
    According to our (Global Info Research) latest study, the global Nanoparticle-Mediated Delivery market size was valued at USD 4704.1 million in 2022 and is forecast to a readjusted size of USD 6001.4 million by 2029 with a CAGR of 3.5% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
    Global Nanoparticle Drug Delivery Systems key players include Gilead Sciences, CSPC, Pacira, Alnylam, etc. Global top four manufacturers hold a share about 37%.
    Asia-Pacific is the largest market, with a share about 37%, followed by Europe, and North America, both have a share over 56 percent.
    In terms of product, Liposomes Drugs is the largest segment, with a share over 92%. And in terms of application, the largest application is Retail Pharmacy, followed by Hospital, etc.
    This report is a detailed and comprehensive analysis for global Nanoparticle-Mediated Delivery market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
    Key Features:
    Global Nanoparticle-Mediated Delivery market size and forecasts, in consumption value ($ Million), 2018-2029
    Global Nanoparticle-Mediated Delivery market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
    Global Nanoparticle-Mediated Delivery market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
    Global Nanoparticle-Mediated Delivery market shares of main players, in revenue ($ Million), 2018-2023
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Nanoparticle-Mediated Delivery
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Nanoparticle-Mediated Delivery market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AbbVie, BlueWillow Biologics, NovaSOL, Camurus and Ceramisphere, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
    Market segmentation
    Nanoparticle-Mediated Delivery market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Biological Origin
    Non-Biological Origin
    Market segment by Application
    Drug Delivery
    Gene Delivery
    Market segment by players, this report covers
    AbbVie
    BlueWillow Biologics
    NovaSOL
    Camurus
    Ceramisphere
    Celgene, CytImmune
    Cristal Therapeutics
    EnColl
    Lena Nanoceutics Ltd.
    EyePoint Pharmaceuticals
    Nanobiotix
    NanoCarrier
    Nanospectra
    NanOlogy
    Selecta Biosciences
    Parvus Therapeutics
    Starpharma
    Tarveda Therapeutics
    Market segment by regions, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
    South America (Brazil, Argentina and Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Nanoparticle-Mediated Delivery product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Nanoparticle-Mediated Delivery, with revenue, gross margin and global market share of Nanoparticle-Mediated Delivery from 2018 to 2023.
    Chapter 3, the Nanoparticle-Mediated Delivery competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Nanoparticle-Mediated Delivery market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
    Chapter 12, the key raw materials and key suppliers, and industry chain of Nanoparticle-Mediated Delivery.
    Chapter 13, to describe Nanoparticle-Mediated Delivery research findings and conclusion.

    Buy now